News

July 12-16, 2026 (London, England) A large group of faculty and staff will represent the MGH FTD Unit in presenting the latest of our exciting research progress at the Alzheimer’s [...]

April 30, 2026 We are pleased to share that Axsome Therapeutics’ Auvelity has been granted FDA approval for the treatment of agitation associated with Alzheimer’s dementia. As the first [...]

June 20, 2026 The fifth episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]

June 17, 2026 Providence, RI Katie Brandt, the MGH FTD Unit’s Director of Caregiver Support Services and Public Relations, was a featured speaker at the Alzheimer’s Foundation of [...]

May 27-30, 2026 In its 29th year, Brad Dickerson, MD, Director of the MGH FTD Unit, had the honor of co-directing the annual Harvard Medical School’s Dementia: A Comprehensive Update [...]

May 20, 2026 The fourth episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]

June 25, 2026 at 7:15 PM
Concord, MA

June 4, 2026 at 10:30 AM
Lincoln, MA

April 20, 2026 The third episode of the second season of From Care to Cure, a podcast from the Massachusetts General Hospital Frontotemporal Disorders Unit, is available today. In season two, [...]

April 15, 2026 Dr. Alexandra Touroutoglou, Director of Imaging Operations of the MGH Frontotemporal Disorders Unit and Associate Professor of Neurology at Harvard Medical School, was interviewed [...]